nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Accelerated partial breast irradiation with perioperative multicatheter interstitial brachytherapy—A feasibility study
|
Pohanková, Denisa |
|
2018 |
17 |
6 |
p. 949-955 |
artikel |
2 |
A novel rectal applicator for contact radiotherapy with HDR 192Ir sources
|
Bellezzo, Murillo |
|
2018 |
17 |
6 |
p. 1037-1044 |
artikel |
3 |
A revised dosimetric characterization of 60Co BEBIG source: From single-source data to clinical dose distribution
|
Abdollahi, Sara |
|
2018 |
17 |
6 |
p. 1011-1022 |
artikel |
4 |
Combining brachytherapy and immunotherapy to achieve in situ tumor vaccination: A review of cooperative mechanisms and clinical opportunities
|
Patel, Ravi B. |
|
2018 |
17 |
6 |
p. 995-1003 |
artikel |
5 |
Cost-effectiveness of prostate boost with high-dose-rate brachytherapy versus intensity-modulated radiation therapy in the treatment of intermediate-high risk prostate cancer
|
Vu, Charles C. |
|
2018 |
17 |
6 |
p. 852-857 |
artikel |
6 |
Declining brachytherapy utilization for high-risk prostate cancer—Can clinical pathways reverse the trend?
|
Ling, Diane C. |
|
2018 |
17 |
6 |
p. 895-898 |
artikel |
7 |
Does adjuvant concurrent or sequential chemotherapy increase the radiation-related toxicity of vaginal brachytherapy for endometrial cancer patients?
|
Nieto, Karina |
|
2018 |
17 |
6 |
p. 929-934 |
artikel |
8 |
Does postoperative irradiation improve survival in early-stage endometrial cancer?
|
Sabater, Sebastia |
|
2018 |
17 |
6 |
p. 912-921 |
artikel |
9 |
Editorial Board
|
|
|
2018 |
17 |
6 |
p. A5 |
artikel |
10 |
Endobronchial brachytherapy—A novel approach for the management of airway amyloidosis
|
Moore, Assaf |
|
2018 |
17 |
6 |
p. 966-972 |
artikel |
11 |
Endobronchial brachytherapy in the management of lung malignancies: 20 years of experience in an Australian center
|
Knox, Matthew C. |
|
2018 |
17 |
6 |
p. 973-980 |
artikel |
12 |
Evaluation of effective treatment depth in skin cancer treatments with electronic brachytherapy
|
Lloyd, Samantha A.M. |
|
2018 |
17 |
6 |
p. 990-994 |
artikel |
13 |
High-dose-rate interstitial brachytherapy as monotherapy in one fraction of 20.5 Gy for the treatment of localized prostate cancer: Toxicity and 6-year biochemical results
|
Prada, Pedro J. |
|
2018 |
17 |
6 |
p. 845-851 |
artikel |
14 |
High-volume providers and brachytherapy practice: A Medicare provider utilization and payment analysis
|
Hong, Julian C. |
|
2018 |
17 |
6 |
p. 906-911 |
artikel |
15 |
Inferring postimplant dose distribution of salvage permanent prostate implant (PPI) after primary PPI on CT images
|
Girum, Kibrom Berihu |
|
2018 |
17 |
6 |
p. 866-873 |
artikel |
16 |
Long-term outcomes analysis of low-dose-rate brachytherapy in clinically T3 high-risk prostate cancer
|
Agarwal, Manuj |
|
2018 |
17 |
6 |
p. 882-887 |
artikel |
17 |
Masthead
|
|
|
2018 |
17 |
6 |
p. A1 |
artikel |
18 |
Modeling of the direction modulated brachytherapy tandem applicator using the Oncentra Brachy advanced collapsed cone engine
|
Safigholi, Habib |
|
2018 |
17 |
6 |
p. 1030-1036 |
artikel |
19 |
Multi-institutional evaluation of the reproducibility and the accuracy of the objective breast cosmesis scale
|
Lancellotta, Valentina |
|
2018 |
17 |
6 |
p. 944-948 |
artikel |
20 |
Multivariate normal tissue complication probability modeling of vaginal late toxicity after brachytherapy for cervical cancer
|
Annede, Pierre |
|
2018 |
17 |
6 |
p. 922-928 |
artikel |
21 |
Outcomes of choroidal melanomas treated with eye physics plaques: A 25-year review
|
Le, Bao Han A. |
|
2018 |
17 |
6 |
p. 981-989 |
artikel |
22 |
Perioperative high-dose-rate brachytherapy in locally advanced and recurrent gynecological cancer: Final results of a Phase II trial
|
Martínez-Monge, Rafael |
|
2018 |
17 |
6 |
p. 1045 |
artikel |
23 |
Phase II study of intraoperative dosimetry for prostate brachytherapy using registered ultrasound and fluoroscopy
|
Lee, Junghoon |
|
2018 |
17 |
6 |
p. 858-865 |
artikel |
24 |
Predicting the necessity of adding catheters to intracavitary brachytherapy for women undergoing definitive chemoradiation for locally advanced cervical cancer
|
Palhares, Daniel Moore Freitas |
|
2018 |
17 |
6 |
p. 935-943 |
artikel |
25 |
Prostate-specific antigen bounce in patients treated before 60 years old by iodine 125 brachytherapy for prostate cancer is frequent and not a prognostic factor
|
Charret, J. |
|
2018 |
17 |
6 |
p. 888-894 |
artikel |
26 |
Prostate-specific antigen doubling time is a significant predictor of overall and disease-free survival in patients with prostate adenocarcinoma treated with brachytherapy
|
Resende Salgado, Lucas |
|
2018 |
17 |
6 |
p. 874-881 |
artikel |
27 |
Real-time dose-rate monitoring with gynecologic brachytherapy: Results of an initial clinical trial
|
Belley, Matthew D. |
|
2018 |
17 |
6 |
p. 1023-1029 |
artikel |
28 |
Reviewers Listing 2018
|
|
|
2018 |
17 |
6 |
p. 1046-1047 |
artikel |
29 |
Selection of patients who would not require long-term prostate-specific antigen monitoring after low-dose-rate brachytherapy
|
Niwa, Naoya |
|
2018 |
17 |
6 |
p. 899-905 |
artikel |
30 |
Skin dose estimation using virtual structures for Contura Multi-Lumen Balloon breast brachytherapy
|
Huang, YuHuei Jessica |
|
2018 |
17 |
6 |
p. 956-965 |
artikel |
31 |
Table of Contents
|
|
|
2018 |
17 |
6 |
p. A2-A4 |
artikel |
32 |
Twitter and brachytherapy: An analysis of “tweets” over six years by patients and health care professionals
|
Thomas, Joel |
|
2018 |
17 |
6 |
p. 1004-1010 |
artikel |
33 |
Using a surgical prostate-specific antigen threshold of >0.2 ng/mL to define biochemical failure for intermediate- and high-risk prostate cancer patients treated with definitive radiation therapy in the ASCENDE-RT randomized control trial
|
Morris, W. James |
|
2018 |
17 |
6 |
p. 837-844 |
artikel |